Clinical Trials Logo

Filter by:
NCT ID: NCT02870686 Completed - Choledocholithiasis Clinical Trials

EUS Guided ERCP in Bile Duct Stone Removal

Start date: May 2013
Phase: N/A
Study type: Interventional

For endoscopist, ERCP for bile duct stone removal is the most widely performed procedure. However, the risk associated radiation exposure to patients and staff are not neglible. Earlier studies, ERCP without the use of fluoroscopy has been reported high success for bile duct stone removal in pregnant patients to prevent radiation exposure to the fetus. EUS is highy accurate technique in detecting common bile duct stone and guiding for therapeutic intervention. There has been a few data from literature showed that EUS guided CBD stone ( CBDS ) removal are equivalent to those following ERCP in term of successful CBDS removal and complications. This randomized trial is designed to address the question that EUS guided CBDS removal is equivalent to ERCP in term of efficacy and safety.

NCT ID: NCT02863328 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus

PIONEER 2
Start date: August 10, 2016
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The aim of this trial is to investigate Efficacy and Safety of Oral Semaglutide versus Empagliflozin in Subjects with Type 2 Diabetes Mellitus.

NCT ID: NCT02862509 Active, not recruiting - Clinical trials for Vertex to Floor Position

Effectiveness of Budesonide Nasal Instillation in a Vertex-to-floor Position

Start date: November 2015
Phase: Phase 2
Study type: Interventional

o Chronic rhinosinusitis is one of the most common health issue affected American population. Surgery plays an important role in the patients who failed the medical treatment. The most difficult location to be operated endoscopically is the frontal sinus. Frontal sinus is also found to be one of the most common sinus for residual and recurrence after the operation. Intranasal steroid seems to be one of the most beneficent post-sinus surgery cares. The topical therapy can be delivered by many approaches. According to the standard clinical practice guideline and recommendations, intranasal corticosteroid spray is suggested. The technique proved to have greater distribution than standard intranasal spray is instillation of steroid nose drops. The head position for instillation of steroid nose drops proven to have a greater access to olfactory cleft and frontal area is Vertex-to-floor position.

NCT ID: NCT02860949 Completed - Clinical trials for Osteoarthritis, Knee

Multimodal Drug Infiltration in Total Knee Arthroplasty: Is Posterior Capsular Infiltration Worth the Risk?

Start date: April 2014
Phase: Phase 2
Study type: Interventional

Multimodal local anesthetic infiltration (LAI) provides effective pain control in patients undergoing total knee arthroplasty (TKA). Some surgeons avoid posterior capsular infiltration (PCI) for fear of damaging posterior neurovascular structures. Data are limited on the added benefits of PCI using different combinations of local anesthetic agents. Therefore, the investigator wanted to know the effectiveness of pain control in LAI with and without PCI. Half of participants received LAI with PCI, while the other half received LAI without PCI during total knee arthroplasty.

NCT ID: NCT02860858 Completed - Clinical trials for Symtomatic Macular Polypoidal Choroidal Vasculopathy

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

Start date: December 30, 2016
Phase: Phase 4
Study type: Interventional

Objective: To evaluate the efficacy of intravitreal aflibercept injection on visual acuity in patients with symptomatic macular PCV.

NCT ID: NCT02859558 Active, not recruiting - HIV-1 Infection Clinical Trials

Early ART to Limit Infection and Establishment of Reservoir

EARLIER
Start date: January 2017
Phase: Phase 2
Study type: Interventional

The study was done to: - Start antiretroviral therapy (ART) early in those recently or acutely infected with HIV-1 - See how starting ART as soon as the infection is found affects the amount of HIV-1 in blood and how well the body fights the HIV-1 infection - Look at the amount of HIV-1 DNA (genetic material for HIV-1) seen in CD4+ T-cells (infection-fighting cells in blood) after 48 weeks of ART - See how early treatment for HIV affects the numbers of HIV-1 infection fighting cells (CD4+ and CD8+ T-cells) in blood

NCT ID: NCT02855606 Completed - Clinical trials for Patient Acceptance of Health Care

Acceptability of HIV Oral PrEP Among MSM and TGW

Start date: December 2015
Phase:
Study type: Observational

The purpose of this study is to determine the factors associated with acceptability to oral HIV pre-exposure prophylaxis (PrEP) among Thai men who have sex with men (MSM) and transgender women (TGW).

NCT ID: NCT02854709 Completed - Glucose Metabolism Clinical Trials

Effects of Sleep Extension on Glucose Metabolism in Chronically Sleep Deprived Individuals

Start date: July 2016
Phase: N/A
Study type: Interventional

This is a randomized cross over study of the effect of 2-week sleep extension in chronically sleep deprived non-diabetic individuals on glucose metabolism.

NCT ID: NCT02854111 Completed - Diabetes Mellitus Clinical Trials

Using of Ice Cream for Diagnosis of Diabetes Mellitus

Start date: July 2013
Phase: N/A
Study type: Interventional

The overall global prevalence of type 2 diabetes mellitus (DM) is rising. Based on the latest Thai National Health Examination Survey, an estimated 3.2 million people had DM, of whom one-third was undiagnosed. The inexpensive oral glucose tolerance test (OGTT) is a more sensitive and reliable test of DM than fasting plasma glucose (FPG) or HbA1c, and is recommended for diagnosing DM and impaired glucose tolerance (IGT). Although the OGTT provides useful diagnostic information, poor patient tolerance of glucose solutions is inevitable.

NCT ID: NCT02849509 Completed - Atrial Fibrillation Clinical Trials

Patient Convenience Study- NIS RELATE

Start date: June 20, 2016
Phase:
Study type: Observational

The aim of this non-interventional study is to describe patient's perception of anticoagulant treatment when using Pradaxa® to prevent stroke and systemic embolism while suffering from atrial fibrillation (according to its approved indication in the approved dosages of 110 mg or 150 mg twice daily) in comparison to standard care using Vitamin K Antagonist (VKA).